{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:08:18Z","timestamp":1787879298499,"version":"build-2784847793"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,27]]},"DOI":"10.1097\/tp.0b013e3181919f5d","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T03:25:50Z","timestamp":1232421950000},"page":"249-255","source":"Crossref","is-referenced-by-count":36,"title":["Predictive Role of Pretransplant Serum CXCL10 for Cardiac Acute Rejection"],"prefix":"10.1097","volume":"87","author":[{"given":"Clara","family":"Crescioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Buonamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Scolletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Sottili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Francalanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Giomarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonizella","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pradella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Maccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00001573-200203000-00002","article-title":"Anything but a biopsy: Noninvasive monitoring for cardiac allograft rejection.","volume":"17","author":"Mehra","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.94.2.695","article-title":"Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.","volume":"94","author":"Strehlau","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM200103293441301","article-title":"Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine.","volume":"344","author":"Li","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCULATIONAHA.106.651521","article-title":"Th1 adaptive immune responses in cardiac graft arteriosclerosis: Deleterious or beneficial?","volume":"114","author":"Tellides","year":"2006","journal-title":"Circulation"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","article-title":"The biology of chemokines and their receptors.","volume":"18","author":"Rossi","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.193.8.975","article-title":"Donor-derived IP-10 initiates development of acute allograft rejection.","volume":"193","author":"Hancock","year":"2001","journal-title":"J Exp Med"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection.","volume":"192","author":"Hancock","year":"2000","journal-title":"J Exp Med"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.169.3.1556","article-title":"Differential expression of the IFN\u03b3-inducible CXCR3-binding chemokines, IFN\u03b3-inducible protein 10, monokine induced by IFN\u03b3, and IFN\u03b3-inducible T Cell chemoattractant in human cardiac allografts: Association with cardiac allograft vasculopathy and acute rejection.","volume":"169","author":"Zhao","year":"2002","journal-title":"J Immunol"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1600-6143.2004.00525.x","article-title":"High pretransplant serum levels of CXCL10\/IP-10 are related to increased risk of renal allograft failure.","volume":"4","author":"Rotondi","year":"2004","journal-title":"Am J Transplant"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000160759.85080.2E","article-title":"High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy.","volume":"79","author":"Lazzeri","year":"2005","journal-title":"Transplantation"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20041709","article-title":"Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.","volume":"201","author":"Lee","year":"2005","journal-title":"J Exp Med"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and Mig\/CXCL9 in the thyroid and increased serum levels of IP-10\/CXCL10 in the serum of subjects with recent onset Graves\u2019 disease.","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am J Pathol"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V92.8.2668","article-title":"Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: An amplification circuit of polarized T helper 2 responses.","volume":"92","author":"Bonecchi","year":"1998","journal-title":"Blood"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/1521-4141(200001)30:1<204::AID-IMMU204>3.0.CO;2-G","article-title":"Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: Preferential association with the production of type 2 cytokines.","volume":"30","author":"Galli","year":"2000","journal-title":"Eur J Immunol"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03345149","article-title":"Role for interferon-gamma inducible chemokines in endocrine autoimmunity: An expanding field.","volume":"26","author":"Rotondi","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"R16-14-20210129","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient. Part I. cardiac rejection and immunosuppressive drugs.","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.healun.2004.01.021","article-title":"Endothelial activation in the transplanted human heart from organ retrieval to 3 months after transplantation: An observational study.","volume":"24","author":"Stoica","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/TP.0b013e318168d571","article-title":"Limited utility of endomyocardial biopsy in the first year after heart transplantation.","volume":"85","author":"Hamour","year":"2008","journal-title":"Transplantation"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/01.tp.0000263338.39555.21","article-title":"Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.","volume":"83","author":"Arora","year":"2007","journal-title":"Transplantation"},{"key":"R21-14-20210129","first-page":"41","article-title":"Principles and practice in renal transplantation.","author":"Stepkowski","year":"2000"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0952-7915(02)00382-5","article-title":"Chemokines: Directing leukocyte infiltration into allografts.","volume":"14","author":"El-Sawy","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/01.tp.0000266892.69117.9a","article-title":"Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.","volume":"83","author":"Haskova","year":"2007","journal-title":"Transplantation"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.02-0908fje","article-title":"Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop.","volume":"18","author":"Campbell","year":"2004","journal-title":"FASEB J"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64126-0","article-title":"CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.","volume":"158","author":"Agostini","year":"2001","journal-title":"Am J Pathol"},{"key":"R26-14-20210129","doi-asserted-by":"crossref","first-page":"24286","DOI":"10.1074\/jbc.271.39.24286","article-title":"Interferon\u03b3-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response.","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.V10122518","article-title":"Role for interactions between IP-10\/Mig and their receptor (CXCR3) in proliferative glomerulonephritis.","volume":"10","author":"Romagnani","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R28-14-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.V13153","article-title":"IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide.","volume":"13","author":"Romagnani","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1074\/jbc.M010303200","article-title":"Signal transduction by the chemokine receptor CXCR3: Activation of Ras\/ERK, Src, and phosphatidylinositol 3-kinase\/Akt controls cell migration and proliferation in human vascular pericytes.","volume":"276","author":"Bonacchi","year":"2001","journal-title":"J Biol Chem"},{"key":"R30-14-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI9775","article-title":"Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.","volume":"107","author":"Romagnani","year":"2001","journal-title":"J Clin Invest"},{"key":"R31-14-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines the regulatory link between inflammation and angiogenesis.","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol"},{"key":"R32-14-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568008053174723","article-title":"CXCR3-binding chemokines: Multifaceted therapeutic targets.","volume":"5","author":"Lazzeri","year":"2005","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"R33-14-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2261-6-29","article-title":"Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.","volume":"6","author":"Karason","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"R34-14-20210129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2003.11.011","article-title":"Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients.","volume":"43","author":"Varagunam","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R35-14-20210129","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients.","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"R36-14-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation\u2014Challenging the status quo.","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"key":"R37-14-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"R38-14-20210129","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.tp.0000230459.22968.26","article-title":"Benefits of cytomegalovirus prophylaxis in solid organ transplantation.","volume":"82","author":"Pescovitz","year":"2006","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200901270-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:49Z","timestamp":1786037449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200901270-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181919f5d","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,27]]}}}